Penumbra (PEN) Operating Expenses (2014 - 2026)
Penumbra's (PEN) quarterly Operating Expenses came in at $215.2 million in Q1 2026, up 22.58% year-on-year from $175.5 million in Q1 2025, and up 6.05% on a QoQ basis from $202.9 million in Q4 2025.
Penumbra (PEN) Operating Expenses (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Operating Expenses data on file, last reported at $215.2 million in Q1 2026.
- On a quarterly basis, Operating Expenses rose 22.58% year-over-year to $215.2 million in Q1 2026; TTM through Mar 2026 was $792.8 million, a 5.4% increase from a year earlier, with the FY2025 full-year figure at $753.2 million, up 1.0% from the prior year.
- Operating Expenses for Q1 2026 stood at $215.2 million, up from $202.9 million in the prior quarter.
- Over the last five years, Operating Expenses for PEN reached as high as $243.8 million in Q2 2024 and fell as low as $129.9 million in Q3 2022.
- Historically, Operating Expenses has averaged $167.8 million across 5 years, with a median of $165.1 million in 2023.
- Across the five-year window, Operating Expenses soared 63.65% in 2024 and slipped 24.86% in 2025, its largest moves.
- Year by year, Operating Expenses stood at $133.6 million in 2022, then rose by 13.75% to $152.0 million in 2023, then rose by 10.52% to $167.9 million in 2024, then grew by 20.81% to $202.9 million in 2025, then increased by 6.05% to $215.2 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $215.2 million in Q1 2026, $202.9 million in Q4 2025, and $191.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.82 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.87 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.59 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.51 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 785.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 495.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -668.50 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 1.46 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -47.00 Mn |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 215.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 215.18 Mn |
| Dec 31, 2025 | 202.90 Mn |
| Sep 30, 2025 | 191.58 Mn |
| Jun 30, 2025 | 183.18 Mn |
| Mar 31, 2025 | 175.53 Mn |
| Dec 31, 2024 | 167.95 Mn |
| Sep 30, 2024 | 164.94 Mn |
| Jun 30, 2024 | 243.79 Mn |
| Mar 31, 2024 | 169.04 Mn |
| Dec 31, 2023 | 151.96 Mn |
| Sep 30, 2023 | 165.09 Mn |
| Jun 30, 2023 | 148.97 Mn |
| Mar 31, 2023 | 143.06 Mn |
| Dec 31, 2022 | 133.59 Mn |
| Sep 30, 2022 | 129.89 Mn |
| Jun 30, 2022 | 134.17 Mn |
| Mar 31, 2022 | 131.46 Mn |
| Dec 31, 2021 | 165.50 Mn |
| Sep 30, 2021 | 111.13 Mn |
| Jun 30, 2021 | 108.37 Mn |